CONTENIDO

CROI 2015 | 22nd Conference on Retroviruses and Opportunistic Infections

23.02.15 - 26.02.15

 

The 22nd Conference on Retroviruses and Opportunistic Infections (CROI 2014) will be held in Seattle, Washington, USA, from February 23 to 26, 2015.

 

 

 

Download the schedule of events

- Important dates Click here

- General Registration: January 27, 2014 Click here

 

 

 

The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI is a global model of collaborative science and the premier international venue for bridging basic and clinical investigation into clinical practice in the field of HIV and related viruses. CROI 2015 will be held from February 23 to February 26, 2015, in Seattle, Washington, at the Washington State Convention Center. Webcasts, abstracts, electronic posters, and other electronic resources from CROI 2015 will be available online via webcast.

 

The CROI Foundation has partnered with the International Antiviral Society–USA (IAS–USA) to sponsor the Conference. 

 

More information

See also: POST CROI. Update conference (to be held in Barcelona). By: Fight AIDS Foundation flsida.org

 

Publicacions o ponències relacionades amb el congrés

Differentiation Stimuli Strongly Impact the Ability of Macrophages to Support HIV-1 Replication Due to SAMHD1 Restriction


Ester Ballana1; Roger Badia1; Eva Riveira-Muñoz1; Alba Ruíz1; Javier Torres-Torronteras2; Bonaventura Clotet1; Eduardo Pauls1; Ramon Marti2; José Esté1

1IrsiCaixa Institute for AIDS Research, Badalona, Spain; 2Institut de Recerca Hospital Universitari Vall d’Hebron, Barcelona, Spain

Essential Role of Cyclin D3 in dNTP Pool Control and HIV-1 Replication in Macrophages

Ester Ballana1; Roger Badia1; Eva Riveira-Muñoz1; Alba Ruíz1; Javier Torres-Torronteras2; Bonaventura Clotet1; Eduardo Pauls1; Ramon Marti2; José Esté1

1IrsiCaixa Institute for AIDS Research, Badalona, Spain; 2 Institut de Recerca Hospital Universitari Vall d’Hebron, Barcelona, Spain

Functional Profiling of the Gut Microbiome in HIV Infection

Yolanda Guillén; Marc Noguera-Julian; Muntsa Rocafort; Mariona Parera; Maria Casadellà; Isabel Bravo; Josep Coll; Julià Blanco; Bonaventura Clotet; Roger Paredes

IrsiCaixa AIDS Res Inst, Hosp Univ Germans Trias i Pujol, Univ Autònoma de Barcelona, Badalona, Spain

Gut Microbiota Correlates with HIV-1 Control and Immune Status

 

Muntsa Rocafort; Marc Noguera-Julian; Yolanda Guillén; Mariona Parera; Maria Casadellà; Isabel Bravo; Josep Coll; Julià Blanco; Bonaventura Clotet; Roger Paredes

 

IrsiCaixa AIDS Res Inst, Hosp Univ Germans Trias i Pujol, Univ Autònoma de Barcelona, Badalona, Spain


Siglec-1 on Monocytes From Untreated HIV-1– Infected Patients Enhances HIV-1 Transfer

 

Maria Pino; Susana Benet; Itziar Erkizia; Judith Dalmau; Dan Ouchi; Bonaventura Clotet; Javier Martínez-Picado; Nuria Izquierdo-Useros

 

IrsiCaixa Institute for AIDS Research, Badalona, Spain


A Random Forest Approach to Define Immunological Thresholds for CD4 Recovery in HIV-Treated Individuals

 

Josué Pérez-Santiago 1; Marta Massanella 1; Dan Ouchi 2; Elisabet Gómez 2; Cecilia Cabrera 2; Bonaventura Clotet 3; Eugenia Negredo 3; Julià Blanco 2


1University of California San Diego, La Jolla, CA, US; 2 IrsiCaixa Institute for AIDS Research, Badalona, Spain; 3 Lluita Contra la Sida Foundation,Germans Trias i Pujol University Hospital, Badalona, Spain

Impact of IFNα-2a on the Replication-Competent HIV-1 Reservoir in CD4+ T Cells

Sara Morón-López2; Maria Salgado2; Dan Ouchi2; Mari Carmen Puertas2; Toni Jou3; Cristina Tural3; Jordi Navarro1; Mercedes Perez-Bernal1; Manel Crespo1; Javier Martínez-Picado2

1Hospital Universitari Vall d’Hebron, Barcelona, Spain; 2AIDS Research Institute irsiCaixa, Barcelona, Spain; 3Fundació Lluita contra la SIDA, Barcelona, Spain


Allogeneic Transplantation With CCR5 Δ32/Δ32 Cord Blood Hematopoietic Cells in an HIV-1-Infected Patient

Rafael Duarte1; Maria Salgado2; Isabel Sanchez-Ortega1; Sara Morón-López2; Maria C. Puertas2; Lawrenze D. Petz4; Sergi Querol3; Bonaventura Clotet 2; Javier Martínez-Picado2

1Institut Català d’Oncologia, L’Hospitalet del Llobregat, Spain; 2 IrsiCaixa Institute for AIDS Research, Badalona, Spain; 3 Barcelona Cord Blood Bank, Barcelona, Spain; 4 StemCyte International Cord Blood Center, Covina, CA, US


Influence of Codon Pair Usage in the Evolvability of HIV-1

Maria Nevot; Cristina Andrés; Mariona Parera; Glòria Martrus; Miguel Ángel Martínez

IrsiCaixa Institute for AIDS Research, Badalona, Spain

Tenofovir Replacement in Patients With Osteoporosis Increased Sclerostin Levels

Eugenia Negredo 3; Adolfo Díez-Pérez 2; Pere Domingo 4; Nuria Pérez-Álvarez 6; Mar Gutierrez 4; Gracia Mateo 4; Jordi Puig 1; Patricia Echeverria 1; Anna Bonjoch 1; Bonaventura Clotet 5


1Lluita Contra la Sida Foundation, Germans Trias i Pujol University Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain; 2 Hospital del Mar-IMIM, Universitat Autònoma de Barcelona and RETICEF, Instituto Carlos III Madrid, Barcelona, Spain; 3 Lluita Contra la Sida Foundation, Germans Trias i Pujol University Hospital, Universitat Autònoma de Barcelona, Universitat de Vic–Universitat Central de Catalunya, Barcelona, Spain; 4 Santa Creu i Sant Pau Hospital, Universitat Autònoma de Barcelona, Barcelona, Spain; 5 Lluita Contra la Sida Foundation, Germans Trias i Pujol University Hospital, Universitat Autònoma de Barcelona, Irsicaixa Foundation, Germans Trias i Pujol University Hospital, Barcelona, Spain; 6 Lluita Contra la Sida Foundation, Germans Trias i Pujol University Hospital, Universitat Autònoma de Barcelona, Statistics and Operations Research Department, Universitat Politècnica de Catalunya, Barcelona, Spain


Oral Single-Dose Maraviroc Does Not Prevent Ex Vivo HIV Infection of Rectal Mucosa in Healthy HIV-1 – Negative Human Volunteers in Tissue Explants

 

Josep Coll 2; José Moltó 2; Jaume Boix 3; Laura Else 4; Elisabet Garcia 1; Roger Paredes 2; David Back 4; Bonaventura Clotet 5; Cecilia Cabrera 1


1 Institut de Recerca de la Sida IrsiCaixa, Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain; 2 Fundació Lluita Contra la SIDA, Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Barcelona, Spain; 3 Unidad de Endoscopia Digestiva. Hospital Universitario Germans Trias i Pujol, Barcelona, Spain; 4 Pharmacology Research Laboratories, Liverpool, United Kingdom; 5 Fundació Lluita Contra la SIDA-IRSICAIXA, VIC-UCC (Universitat de Vic-Universitat Central de Catalunya), Barcelona, Spain